High-fidelity SaCas9 identified by directional screening in human cells
Open Access
- 9 July 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 18 (7) , e3000747
Abstract
CRISPR-Staphylococcus aureus Cas9 (CRISPR-SaCas9) has been harnessed as an effective in vivo genome-editing tool to manipulate genomes. However, off-target effects remain a major bottleneck that precludes safe and reliable applications in genome editing. Here, we characterize the off-target effects of wild-type (WT) SaCas9 at single-nucleotide (single-nt) resolution and describe a directional screening system to identify novel SaCas9 variants with desired properties in human cells. Using this system, we identified enhanced-fidelity SaCas9 (efSaCas9) (variant Mut268 harboring the single mutation of N260D), which could effectively distinguish and reject single base-pair mismatches. We demonstrate dramatically reduced off-target effects (approximately 2- to 93-fold improvements) of Mut268 compared to WT using targeted deep-sequencing analyses. To understand the structural origin of the fidelity enhancement, we find that N260, located in the REC3 domain, orchestrates an extensive network of contacts between REC3 and the guide RNA-DNA heteroduplex. efSaCas9 can be broadly used in genome-editing applications that require high fidelity. Furthermore, this study provides a general strategy to rapidly evolve other desired CRISPR-Cas9 traits besides enhanced fidelity, to expand the utility of the CRISPR toolkit.Keywords
Funding Information
- National Natural Science Foundation of China (81201181)
- National Natural Science Foundation of China (81700885)
- National Natural Science Foundation of China (81670882)
This publication has 41 references indexed in Scilit:
- Genome-wide identification of CRISPR/Cas9 off-targets in human genomeCell Research, 2014
- Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cellsScientific Reports, 2014
- Engineering adeno-associated viruses for clinical gene therapyNature Reviews Genetics, 2014
- Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editingNature Biotechnology, 2014
- Improving CRISPR-Cas nuclease specificity using truncated guide RNAsNature Biotechnology, 2014
- Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleasesBioinformatics, 2014
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing SpecificityCell, 2013
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- RNA-guided editing of bacterial genomes using CRISPR-Cas systemsNature Biotechnology, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012